BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 21, 2020
View Archived Issues
New search method, new antibiotic MOA
Read More
JAK inhibitors build bone, no inflammation necessary
Read More
FDA approves IND application for phase IIb study of CMN-001 in advanced RCC
Read More
Passengers, noncoding genome affect how cancers play out
Read More
Mesoblast reports clinically meaningful outcomes for remestemcel-L in chronic GVHD
Read More
Enrollment ongoing in phase I/II study of MB-102
Read More
Novartis initiates first-in-human trial of WVT-078 in multiple myeloma
Read More
VBL initiates phase II study of VB-111 and nivolumab in metastatic colorectal cancer
Read More
Results from ongoing phase I study of ciforadenant with or without atezolizumab in mCRPC
Read More
BT-200 blocks VWF and platelet function in whole blood of patients with acute stroke
Read More
AT-845 shows safety and robust efficacy in preclinical models
Read More
New CDK8/19 inhibitors described by Biocad CJSC
Read More
Bristol-Myers Squibb discovers toll-like receptor 7 agonists
Read More
Sumitomo Dainippon Pharma describes anticancer chromen derivatives
Read More
Artios Pharma patents DNA polymerase eta inhibitors
Read More
Antabio SAS discovers serine beta-lactamase inhibitors
Read More
Oncofid-P-b shows promise in bladder cancer patients unresponsive to BCG
Read More
Chloroquine phosphate improves COVID-19-associated pneumonia in patients
Read More
EncuraGen presents new ADIPOR1 agonist BHD-1028 for type 2 diabetes, obesity and NASH
Read More
Phase IIb/III study of oral masitinib in PPMS and nSPMS meets primary endpoint
Read More
FDA approves Anjeso for moderate to severe pain
Read More
New phase I/IIa trial studies IHA infusion of TG-6002 for liver metastases from colorectal cancer
Read More
Agenus reports new data from cancer immunotherapy programs
Read More
Opdivo approved in Japan for advanced esophageal cancer
Read More